| Molecule | Cat. No. | Product Name | Species | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| NPR1 | HOTAvitag NP1-H82E9 | Biotinylated Human NPR1 / NPRA Protein, His,Avitag™ (MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $360.00 25ug | |
| NPR1 | HOT NP1-H5259 | Human NPR1 / NPRA Protein, Fc Tag (MALS verified) | Human | HEK293 |  | MALSSDS-PAGE | $430.00 100ug | |
| NPR1 | HOT NP1-M52H3 | Mouse NPR1 / NPRA Protein, His Tag, low endotoxin (MALS verified) |  Mouse | HEK293 | MALSSDS-PAGE | $395.00 100ug | ||
| NPR1 | Cynomolgus NPR1 / NPRA Protein, His Tag, low endotoxin (MALS verified) |  Cynomolgus | HEK293 | MALSSDS-PAGE | $385.00 100ug | |||
| NPR1 | Human NPR1 / NPRA Protein, His Tag (MALS verified) | Human | HEK293 | MALSSDS-PAGE | $385.00 100ug |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide(Shijiazhuang wotai) | Phase 3 Clinical | Shijiazhuang wotai Biotechnology Co Ltd | Acutely decompensated congestive heart failure; Heart Failure | Details | |
| Recombinant human brain natriuretic peptide (Shanghai Jiao Tong University) | Phase 3 Clinical | Shanghai Jiaotong University | Heart Defects, Congenital; Tetralogy of Fallot | Details | |
| Nesiritide | BNP-32 (human); JNS-004; hBNP; SC-70400 | Phase 2 Clinical | Johnson & Johnson | Acutely decompensated congestive heart failure; Cardiomyopathies; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Dyspnea; Heart Failure; Heart Failure, Systolic; Hyperemia; Hyperinsulinism; Hypertension; Myocardial Ischemia; Obesity; Renal Insufficiency; Sleep Disorders, Circadian Rhythm | Details |
| Baloncibart | REGN-7544; REGN7544 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Hypotension; Postural Orthostatic Tachycardia Syndrome | Details |
| XXB-750 | XXB-750 | Phase 2 Clinical | Novartis Pharma Ag | Heart Failure; Heart Failure, Systolic; Hypertension | Details |
| GNP | Phase 2 Clinical | Guangzhou Leien Kangya Biomedical Technology Co Ltd | Acutely decompensated congestive heart failure; Heart Failure | Details | |
| REGN-5381 | REGN-5381 | Phase 2 Clinical | Regeneron Pharmaceuticals Inc | Heart Failure; Hypertension | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Recombinant human brain natriuretic peptide (Tibet Rhodiola) | Approved | Tibet Rhodiola Pharmaceutical Holding Company | 新活素 | Mainland China | Heart Failure | Chengdu Rhodiola Bio-Pharmaceutical Co Ltd | 2005-04-11 | Acutely decompensated congestive heart failure; Heart Failure | Details | |
| Sodium Nitroprusside | SNP | Approved | F. Hoffmann-La Roche Ltd | Nipride, Nitriate, Nitropress | Mainland China | Heart Failure; Hypertension | China Resources Double-Crane Pharmaceutical Co Ltd | 1974-05-10 | Healthy Aging; Heart Failure; Hypertension; Hypotension; Myocardial Infarction; Pulmonary Edema; Schizophrenia | Details |
| Recombinant human brain natriuretic peptide (Suzhou Landing Bioteh) | Approved | Suzhou RxD Biopharmaceutical Co Ltd | Mainland China | Heart Failure | Suzhou RxD Biopharmaceutical Co Ltd | 2025-04-30 | Heart Failure | Details | ||
| Carperitide | SUN-Y4936r; alpha-hANP; ANF (99-126); SUN-4936r; ANP (99-126); CDD (99-126); SUN-4936; SUN-4936h | Approved | Daiichi Sankyo Co Ltd | HANP | Japan | Heart Failure | Daiichi Sankyo Co Ltd | 1995-01-20 | Cardiomyopathies; Heart Failure; Respiratory Distress Syndrome, Adult | Details |
